Krystal Biotech
KRYS
KRYS
333 hedge funds and large institutions have $7.02B invested in Krystal Biotech in 2025 Q4 according to their latest regulatory filings, with 81 funds opening new positions, 112 increasing their positions, 104 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
1.39% more ownership
Funds ownership: 96.77% → 98.16% (+1.4%)
8% more repeat investments, than reductions
Existing positions increased: 112 | Existing positions reduced: 104
Holders
333
Holding in Top 10
8
Calls
$53M
Puts
$21.6M
Top Buyers
| 1 | +$86.1M | |
| 2 | +$47.8M | |
| 3 | +$44.1M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$23.4M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$22.3M |
Top Sellers
| 1 | -$67M | |
| 2 | -$52.7M | |
| 3 | -$42.1M | |
| 4 |
UBS AM
Chicago,
Illinois
|
-$35.6M |
| 5 |
Millennium Management
New York
|
-$28.2M |
